Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 20 Dec 2021

Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children’s Leukemia Group

in Hematologic Malignancies

Kun-yin Qiu
Hong-gui Xu
Xue-qun Luo
Hui-rong Mai
Ning Liao
Li-hua Yang
Min-cui Zheng
Wu-qing Wan
Xue-dong Wu
Ri-yang Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.797194

10,350 views
22 citations

Original Research

Published on 17 Dec 2021

SAMHD1 Mutations and Expression in Mantle Cell Lymphoma Patients

in Hematologic Malignancies

Tao Wang
Wenqin Yue
Gusheng Tang
Mingyu Ye
Jiechen Yu
Bin Liu
Lijuan Jiao
Xuefei Liu
Shuyi Yin
Jie Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.763151

4,627 views
12 citations

Review

Published on 16 Dec 2021

Treatment of AML Relapse After Allo-HCT

in Hematologic Malignancies

Jonathan A. Webster
Leo Luznik
Ivana Gojo

Frontiers in Oncology

doi 10.3389/fonc.2021.812207

23,560 views
35 citations

Original Research

Published on 16 Dec 2021

Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study

in Hematologic Malignancies

Xue Shi
Xiaoqian Liu
Xiaomei Li
Yahan Li
Dongyue Lu
Xue Sun
Ying Li
Shunfeng Hu
Yuanfeng Zhang
Xiangxiang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.754964

7,595 views
15 citations

Review

Published on 16 Dec 2021

Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective

in Hematologic Malignancies

Marwan Kwok
Catherine J. Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.790004

12,939 views
16 citations

Editorial

Published on 15 Dec 2021

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Disease Biology and Signaling

in Hematologic Malignancies

Jérôme Paggetti
Martina Seiffert
Etienne Moussay

Frontiers in Oncology

doi 10.3389/fonc.2021.820984

2,211 views

Original Research

Published on 14 Dec 2021

Maternal and Fetal Outcomes of Acute Leukemia in Pregnancy: A Retrospective Study of 52 Patients

in Hematologic Malignancies

Peng Wang
Zhen Yang
Meng Shan
Shenqi Lu
Luwei Zhang
Shijia Li
Shuhong Hu
Hong Tian
Yang Xu
Depei Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.803994

10,965 views
12 citations

Case Report

Published on 13 Dec 2021

Successful Outcome of Patellectomy Plus Chemotherapy for Primary Bone Lymphoma of the Patella: A Case Report and Literature Review

in Hematologic Malignancies

Xin Cao
Hui-Jin Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.786495

2,028 views
3 citations

Case Report

Published on 13 Dec 2021

Case Report: Early Association of Vemurafenib to Standard Chemotherapy in Multisystem Langerhans Cell Histiocytosis in a Newborn: Taking a Chance for a Better Outcome?

in Hematologic Malignancies

Stefania Gaspari
Valentina Di Ruscio
Francesca Stocchi
Roberto Carta
Marco Becilli
Maria Antonietta De Ioris

Frontiers in Oncology

doi 10.3389/fonc.2021.794498

3,481 views
7 citations

Mini Review

Published on 13 Dec 2021

Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

in Hematologic Malignancies

Konstantinos Liapis
Ioannis Kotsianidis

Frontiers in Oncology

doi 10.3389/fonc.2021.801524

12,630 views
11 citations

Original Research

Published on 09 Dec 2021

Nomogram Model for Dynamic and Individual Prediction of Cardiac Response and Survival for Light Chain Amyloidosis in 737 Patients With Cardiac Involvement

in Hematologic Malignancies

Yang Li
Yanze Cao
Mingxin Zheng
Jiaqi Hu
Wei Yan
Xiaoyu Liu
Aijun Liao
Wei Yang
Jian Li
Huihan Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.758502

2,389 views
2 citations

Case Report

Published on 09 Dec 2021

Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome

in Hematologic Malignancies

Georg-Nikolaus Franke
Konstantin Dumann
Madlen Jentzsch
Astrid Monecke
Christine Doehring
Claudia Nehring-Vucinic
Sebastian Schwind
Dietger Niederwieser
Uwe Platzbecker
Mirjana Ziemer

Frontiers in Oncology

doi 10.3389/fonc.2021.749691

3,045 views
1 citation

Review

Published on 09 Dec 2021

Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features

in Hematologic Malignancies

Lina van der Straten
Paul J. Hengeveld
Arnon P. Kater
Anton W. Langerak
Mark-David Levin

Frontiers in Oncology

doi 10.3389/fonc.2021.780085

9,532 views
9 citations

Original Research

Published on 08 Dec 2021

Herbal NF-κB Inhibitors Sensitize Rituximab-Resistant B Lymphoma Cells to Complement-Mediated Cytolysis

in Hematologic Malignancies

Xiaowen Ge
Yiqun Du
Jianfeng Chen
Na Zhu
Jiamei Yao
Xin Zhang
Na Wang
Yujing Sun
Feng Gao
Weiguo Hu

Frontiers in Oncology

doi 10.3389/fonc.2021.751904

6,971 views
6 citations

Review

Published on 08 Dec 2021

Tumor Microenvironment of Lymphomas and Plasma Cell Neoplasms: Broad Overview and Impact on Evaluation for Immune Based Therapies

in Hematologic Malignancies

Sudhir Perincheri

Frontiers in Oncology

doi 10.3389/fonc.2021.719140

3,536 views
7 citations

Original Research

Published on 08 Dec 2021

Integration of a Geriatric Assessment With Intervention in the Care of Older Adults With Hematologic Malignancies

in Hematologic Malignancies

Sarah A. Wall
Ying Huang
Ashleigh Keiter
Allesia Funderburg
Colin Kloock
Nicholas Yuhasz
Tanya R. Gure
Edmund Folefac
Erin Stevens
Carolyn J. Presley

Frontiers in Oncology

doi 10.3389/fonc.2021.775050

4,933 views
13 citations

Original Research

Published on 07 Dec 2021

Long-Term Mixed Chimerism After Ex Vivo/In Vivo T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms

in Hematologic Malignancies

Leo Ruhnke
Friedrich Stölzel
Uta Oelschlägel
Malte von Bonin
Katja Sockel
Jan Moritz Middeke
Christoph Röllig
Korinna Jöhrens
Johannes Schetelig
Christian Thiede

Frontiers in Oncology

doi 10.3389/fonc.2021.776946

3,591 views
2 citations

Clinical Trial

Published on 06 Dec 2021

Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi

in Hematologic Malignancies

Laura Ballotta
Pier Luigi Zinzani
Stefano Pileri
Riccardo Bruna
Monica Tani
Beatrice Casadei
Valentina Tabanelli
Stefano Volpetti
Stefano Luminari
Paolo Corradini

Frontiers in Oncology

doi 10.3389/fonc.2021.789891

5,139 views
9 citations

Original Research

Published on 06 Dec 2021

High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL

in Hematologic Malignancies

Lu-Lu Wang
Dehong Yan
Xue Tang
Mengqi Zhang
Shilin Liu
Ying Wang
Min Zhang
Guichi Zhou
Tonghui Li
Feifei Jiang

Frontiers in Oncology

doi 10.3389/fonc.2021.755188

4,398 views
9 citations

Original Research

Published on 06 Dec 2021

Early Dynamics and Depth of Response in Multiple Myeloma Patients Treated With BCMA CAR-T Cells

in Hematologic Malignancies

Sandy W. Wong
Nina Shah
Guy Ledergor
Thomas Martin
Jeffrey Wolf
Amy M. Shui
Chiung-Yu Huang
Joaquin Martinez-Lopez

Frontiers in Oncology

doi 10.3389/fonc.2021.783703

6,435 views
11 citations

Original Research

Published on 06 Dec 2021

Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome

in Hematologic Malignancies

Shuyan Yao
Zhili Jin
Lingbo He
Ruoxi Zhang
Menghan Liu
Zhengjie Hua
Zhao Wang
Yini Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.788056

4,730 views
19 citations

Original Research

Published on 03 Dec 2021

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma

in Hematologic Malignancies

Mengya Zhong
Jinshui Tan
Guangchao Pan
Yuelong Jiang
Hui Zhou
Qian Lai
Qinwei Chen
Liyuan Fan
Manman Deng
Bing Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.780118

6,249 views
8 citations

Review

Published on 02 Dec 2021

Why Single-Cell Sequencing Has Promise in MDS

in Hematologic Malignancies

Xuan Zhang
H. Leighton Grimes

Frontiers in Oncology

doi 10.3389/fonc.2021.769753

7,336 views
4 citations

Systematic Review

Published on 02 Dec 2021

Efficacy and Safety of Lenalidomide Monotherapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma: Systematic Review and Meta-Analysis

in Hematologic Malignancies

Jia Li
Jianpeng Zhou
Wei Guo
Xingtong Wang
Yangzhi Zhao
Ou Bai

Frontiers in Oncology

doi 10.3389/fonc.2021.756728

4,339 views
4 citations

2,059 articles

articles

Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children’s Leukemia Group

SAMHD1 Mutations and Expression in Mantle Cell Lymphoma Patients

Treatment of AML Relapse After Allo-HCT

Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study

Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Disease Biology and Signaling

Maternal and Fetal Outcomes of Acute Leukemia in Pregnancy: A Retrospective Study of 52 Patients

Successful Outcome of Patellectomy Plus Chemotherapy for Primary Bone Lymphoma of the Patella: A Case Report and Literature Review

Case Report: Early Association of Vemurafenib to Standard Chemotherapy in Multisystem Langerhans Cell Histiocytosis in a Newborn: Taking a Chance for a Better Outcome?

Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

Nomogram Model for Dynamic and Individual Prediction of Cardiac Response and Survival for Light Chain Amyloidosis in 737 Patients With Cardiac Involvement

Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome

Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features

Herbal NF-κB Inhibitors Sensitize Rituximab-Resistant B Lymphoma Cells to Complement-Mediated Cytolysis

Tumor Microenvironment of Lymphomas and Plasma Cell Neoplasms: Broad Overview and Impact on Evaluation for Immune Based Therapies

Integration of a Geriatric Assessment With Intervention in the Care of Older Adults With Hematologic Malignancies

Long-Term Mixed Chimerism After Ex Vivo/In Vivo T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms

Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi

High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL

Early Dynamics and Depth of Response in Multiple Myeloma Patients Treated With BCMA CAR-T Cells

Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma

Why Single-Cell Sequencing Has Promise in MDS

Efficacy and Safety of Lenalidomide Monotherapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma: Systematic Review and Meta-Analysis